ABI
LCI

Adamant Biomedical Investments’s Lannett Company, Inc. LCI Stock Holding History

Adamant Biomedical Investments’s Portfolio LCI Stock Details LCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.04M Buy
23,553
+3,553
+18% +$659K 0.97% 38
2014
Q3 		$3.65M Buy
+20,000
New +$3.2M 0.91% 41

Other funds holding LCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Adamant Biomedical Investments's LCI Position: Q4 2014 in Review

Adamant Biomedical Investments increased its Lannett Company, Inc. (LCI) stake by 18% in Q4 2014, buying an estimated $659K and bringing the position to 23,553 shares worth $4.04M. The position accounts for 0.97% of the portfolio, ranked #38.

Adamant Biomedical Investments first reported a position in LCI in Q3 2014 and has held it in 2 quarters since. 205 funds tracked by Wall St. Rank hold LCI as of Q4 2014.

  • Adamant Biomedical Investments held 23,553 shares of Lannett Company, Inc. worth $4.04M as of Q4 2014.
  • Adamant Biomedical Investments bought 3,553 Lannett Company, Inc. shares in Q4 2014, an estimated $659K.
  • Lannett Company, Inc. made up 0.97% of Adamant Biomedical Investments's portfolio in Q4 2014, its #38 holding.
  • Adamant Biomedical Investments first reported a position in Lannett Company, Inc. in Q3 2014 and has held it in 2 quarters since.
  • 205 funds tracked by Wall St. Rank held Lannett Company, Inc. as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.